Pfizer Ltd: Stock Analysis & Fundamentals

Updated this week

Pfizer Ltd (Pharma - MNC bulk Drugs) — fundamental analysis, earnings data, and key metrics. PE: 28.2. ROE: 16.4%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

🌐FII stake decreased 0.9% this quarter

🏛️DII accumulation — stake up 1.1%

Key Numbers

Current Price

₹4,692

Dividend Yield

0.75%

Market Cap

21.5K Cr

Valuation

N/A

Other Top Pharma - MNC bulk Drugs Stocks Beating Nifty 500

Novartis India Ltd

Weak • 6w streak

+36.4%

← Back to Pharma - MNC bulk Drugs Dashboard

Frequently Asked Questions: Pfizer Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Pfizer Ltd's latest quarterly results?

Pfizer Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: +10.9%
Revenue Growth YoY: +19.9%
Operating Margin: 35.0%

What is Pfizer Ltd's current PE ratio?

Pfizer Ltd's current PE ratio is 28.2x.

Current PE: 28.2x
Market Cap: 21.5K Cr
Dividend Yield: 0.75%

What is Pfizer Ltd's price-to-book ratio?

Pfizer Ltd's price-to-book ratio is 5.6x.

Price-to-Book (P/B): 5.6x
Book Value per Share: ₹841
Current Price: ₹4692

Is Pfizer Ltd a fundamentally strong company?

Pfizer Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 22.0%

Is Pfizer Ltd debt free?

Pfizer Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹43 Cr

What is Pfizer Ltd's return on equity (ROE) and ROCE?

Pfizer Ltd's return ratios over recent years

FY2023: ROCE 26.0%
FY2024: ROCE 22.0%
FY2025: ROCE 22.0%

Is Pfizer Ltd's cash flow positive?

Pfizer Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹660 Cr
Free Cash Flow (FCF): ₹589 Cr
CFO/PAT Ratio: 86% (strong cash conversion)

What is Pfizer Ltd's dividend yield?

Pfizer Ltd's current dividend yield is 0.75%.

Dividend Yield: 0.75%
Current Price: ₹4692

Who holds Pfizer Ltd shares — promoters, FII, DII?

Pfizer Ltd's shareholding pattern (Dec 2025)

Promoters: 63.9%
FII (Foreign): 2.7%
DII (Domestic): 17.1%
Public: 16.3%

Is promoter holding increasing or decreasing in Pfizer Ltd?

Pfizer Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 63.9% (Dec 2025)
Previous Quarter: 63.9% (Sep 2025)
Change: 0.00% (stable)

Is Pfizer Ltd a new momentum entry or an established outperformer?

Pfizer Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Pfizer Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Pfizer Ltd may be worth studying

Cash flow is positive — CFO ₹660 Cr

What is the investment thesis for Pfizer Ltd?

Pfizer Ltd investment thesis summary:

What is the future outlook for Pfizer Ltd?

Pfizer Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.